Literature DB >> 34244365

Dynamic Change of Endocannabinoid Signaling in the Medial Prefrontal Cortex Controls the Development of Depression After Neuropathic Pain.

Christina M Mecca1,2, Dongman Chao1, Guoliang Yu1, Yin Feng1, Ian Segel1, Zhiyong Zhang1, Dianise M Rodriguez-Garcia2, Christopher P Pawela1,3, Cecilia J Hillard4,3, Quinn H Hogan1,2,3, Bin Pan5,2,3.   

Abstract

Many patients with chronic pain conditions suffer from depression. The mechanisms underlying pain-induced depression are still unclear. There are critical links of medial prefrontal cortex (mPFC) synaptic function to depression, with signaling through the endocannabinoid (eCB) system as an important contributor. We hypothesized that afferent noxious inputs after injury compromise activity-dependent eCB signaling in the mPFC, resulting in depression. Depression-like behaviors were tested in male and female rats with traumatic neuropathy [spared nerve injury (SNI)], and neuronal activity in the mPFC was monitored using the immediate early gene c-fos and in vivo electrophysiological recordings. mPFC eCB Concentrations were determined using mass spectrometry, and behavioral and electrophysiological experiments were used to evaluate the role of alterations in eCB signaling in depression after pain. SNI-induced pain induced the development of depression phenotypes in both male and female rats. Pyramidal neurons in mPFC showed increased excitability followed by reduced excitability in the onset and prolonged phases of pain, respectively. Concentrations of the eCBs, 2-arachidonoylglycerol (2-AG) in the mPFC, were elevated initially after SNI, and our results indicate that this resulted in a loss of CB1R function on GABAergic interneurons in the mPFC. These data suggest that excessive release of 2-AG as a result of noxious stimuli triggers use-dependent loss of function of eCB signaling leading to excessive GABA release in the mPFC, with the final result being behavioral depression.SIGNIFICANCE STATEMENT Pain has both somatosensory and affective components, so the complexity of mechanisms underlying chronic pain is best represented by a biopsychosocial model that includes widespread CNS dysfunction. Many patients with chronic pain conditions develop depression. The mechanism by which pain causes depression is unclear. Although manipulation of the eCB signaling system as an avenue for providing analgesia per se has not shown much promise in previous studies. An important limitation of past research has been inadequate consideration of the dynamic nature of the connection between pain and depression as they develop. Here, we show that activity-dependent synthesis of eCBs during the initial onset of persistent pain is the critical link leading to depression when pain is persistent.
Copyright © 2021 the authors.

Entities:  

Keywords:  depression; endocannabinoid; medial prefrontal cortex; neuronal activity; neuropathic pain; synaptic transmission

Mesh:

Substances:

Year:  2021        PMID: 34244365      PMCID: PMC8412994          DOI: 10.1523/JNEUROSCI.3135-20.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  71 in total

1.  Quantal components of the end-plate potential.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

2.  Peripheral Neuropathy Induces HCN Channel Dysfunction in Pyramidal Neurons of the Medial Prefrontal Cortex.

Authors:  Steven Cordeiro Matos; Zizhen Zhang; Philippe Séguéla
Journal:  J Neurosci       Date:  2015-09-23       Impact factor: 6.167

Review 3.  Minis: whence and wherefore?

Authors:  Robert S Zucker
Journal:  Neuron       Date:  2005-02-17       Impact factor: 17.173

4.  Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types.

Authors:  Agnes L Bodor; István Katona; Gábor Nyíri; Ken Mackie; Catherine Ledent; Norbert Hájos; Tamás F Freund
Journal:  J Neurosci       Date:  2005-07-20       Impact factor: 6.167

Review 5.  Synaptic functions of endocannabinoid signaling in health and disease.

Authors:  Alfonso Araque; Pablo E Castillo; Olivier J Manzoni; Raffaella Tonini
Journal:  Neuropharmacology       Date:  2017-06-15       Impact factor: 5.250

6.  Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.

Authors:  Laura J Sim-Selley; Nicole S Schechter; W Kirk Rorrer; George D Dalton; Jerry Hernandez; Billy R Martin; Dana E Selley
Journal:  Mol Pharmacol       Date:  2006-06-07       Impact factor: 4.436

7.  Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons.

Authors:  Elisa L Hill; Thierry Gallopin; Isabelle Férézou; Bruno Cauli; Jean Rossier; Paul Schweitzer; Bertrand Lambolez
Journal:  J Neurophysiol       Date:  2007-01-31       Impact factor: 2.714

8.  Learned avoidance from noxious mechanical simulation but not threshold semmes weinstein filament stimulation after nerve injury in rats.

Authors:  Hsiang-En Wu; Geza Gemes; Vasiliki Zoga; Takashi Kawano; Quinn H Hogan
Journal:  J Pain       Date:  2009-11-27       Impact factor: 5.820

9.  Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity.

Authors:  Sachin Patel; David J Rademacher; Cecilia J Hillard
Journal:  J Pharmacol Exp Ther       Date:  2003-06-13       Impact factor: 4.030

Review 10.  The Role of Stress Regulation on Neural Plasticity in Pain Chronification.

Authors:  Xiaoyun Li; Li Hu
Journal:  Neural Plast       Date:  2016-12-08       Impact factor: 3.599

View more
  6 in total

1.  The Ups and Downs of Endocannabinoid Signaling in Chronic Pain-Induced Depression.

Authors:  Nicole Wilkinson
Journal:  J Neurosci       Date:  2022-03-16       Impact factor: 6.709

2.  Brain Functional Alteration at Different Stages of Neuropathic Pain With Allodynia and Emotional Disorders.

Authors:  Ya-Nan Zhang; Xiang-Xin Xing; Liu Chen; Xin Dong; Hao-Tian Pan; Xu-Yun Hua; Ke Wang
Journal:  Front Neurol       Date:  2022-05-02       Impact factor: 4.003

Review 3.  Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment.

Authors:  Raquel Maria P Campos; Andrey F L Aguiar; Yolanda Paes-Colli; Priscila Martins Pinheiro Trindade; Bruna K Ferreira; Ricardo A de Melo Reis; Luzia S Sampaio
Journal:  Front Physiol       Date:  2021-11-30       Impact factor: 4.566

4.  The cAMP Response Element- Binding Protein/Brain-Derived Neurotrophic Factor Pathway in Anterior Cingulate Cortex Regulates Neuropathic Pain and Anxiodepression Like Behaviors in Rats.

Authors:  Jing Wen; Yaowei Xu; Zhixiang Yu; Yifan Zhou; Wenting Wang; Jingjie Yang; Yiming Wang; Qian Bai; Zhisong Li
Journal:  Front Mol Neurosci       Date:  2022-03-24       Impact factor: 5.639

Review 5.  Dissecting the Neural Circuitry for Pain Modulation and Chronic Pain: Insights from Optogenetics.

Authors:  Fang Guo; Yu Du; Feng-Hui Qu; Shi-Da Lin; Zhong Chen; Shi-Hong Zhang
Journal:  Neurosci Bull       Date:  2022-03-05       Impact factor: 5.271

6.  Gut Microbiome and Plasma Metabolome Signatures in Middle-Aged Mice With Cognitive Dysfunction Induced by Chronic Neuropathic Pain.

Authors:  Dongyu Hua; Shan Li; Shiyong Li; Xuan Wang; Yue Wang; Zheng Xie; Yilin Zhao; Jie Zhang; Ailin Luo
Journal:  Front Mol Neurosci       Date:  2022-01-04       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.